B7/CTLA4 pathway is essential for generating regulatory cells after intratracheal delivery of alloantigen in mice

Transplantation

Volumn 74, Issue 5, 2002, Pages 732-738

  Akiyama, Yoshinobu ^a   Shirasugi, Nozomu ^a   Uchida, Norio ^a   Matsumoto, Kenji ^a   Kitajima, Masaki ^a   Bashuda, Hisashi ^a   Yagita, Hideo ^a   Okumura, Ko ^a   Aramaki, Osamu ^a   Niimi, Masanori ^a  

^a TEIKYO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; MONOCLONAL ANTIBODY;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL CULTURE; CELL KINETICS; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HISTOCOMPATIBILITY COMPLEX; IMMUNOREGULATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; SPLEEN CELL; SURVIVAL RATE;

EID: 0037106360     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200209150-00024     Document Type: Article

References (31)

1. Reinsmoen NL, Matas AJ, Donaldson K, et al. Impact of transfusions and acute rejection on posttransplantation donor antigen-specific responses in two study populations. Cooperative Clinical Trial in Transplantation Research Group. Transplantation 1999;67:697.
2. Hadley GA, Anderson CB, Mohanakumar T. Selective loss of functional antidonor cytolytic T cell precursors following donor-specific blood transfusions in long-term renal allograft recipients. Transplantation 1992;54:333.
3. Lenhard V, Massen G, Seifert P, et al. Characterization of transfusion-induced suppressor cells in prospective kidney allograft recipients. Transplant Proc 1982;14(2):329.
4. Bean MA, Mickelson E, Yanagida J, et al. Suppressed antidonor MLR responses in renal transplant candidates conditioned with donor-specific transfusions that carry the recipient's noninherited maternal HLA haplotype. Transplantation 1990;49:382.
5. Phelan DL, Rodey GE, Anderson CB. The development and specificity of antiidiotypic antibodies in renal transplant recipients receiving single-donor blood transfusions. Transplantation 1989;48:57.
6. Weiner HL. Oral tolerance. Proc Natl Acad Sci USA 1994;91:10762.
7. Sayegh MH, Zhang ZJ, Hancock WW, et al. Down-regulation of the immune response to histocompatibility antigens and prevention of sensitization by skin allografts by orally administered antigen. Transplantation 1992;53:163.
8. Hancock WW, Sayegh MH, Kwok CA, et al. Oral, but not intravenous, alloantigen prevents accelerated allograft rejection by selective intragraft Th2 cell activation. Transplantation 1993;55:1112.
9. Kreutzer B, Laliotou B, Cheng YF, et al. Nasal administration of retinal antigens maintains immunosuppression of uveoretinitis in cyclosporin-A-treated Lewis rats: future treatment of endogenous posterior uveoretinitis. Eye 1997;11:445.
10. Lowrey JL, Savage ND, Palliser D, et al. Induction of tolerance via the respiratory mucosa. Int Arch Allergy Immunol 1998;116:93.
11. Shirasugi N, Ikeda Y, Akiyama Y, et al. Induction of hyporesponsiveness to fully allogeneic cardiac grafts by intratracheal delivery of alloantigen. Transplantation 2001;71:561.
12. Niimi M, Hara M, Bushell A, et al. Results of heart transplantation. In: Timmermann W, Gassel H-J, Ulrich K, eds. Organ transplantation in rats and mice: Microsurgical techniques and immunological principles. Berlin, Springer, 1998, pp 637.
13. Bashuda H, Seino K, Kano M, et al. Specific acceptance of cardiac allografts after treatment with antibodies to CD80 and CD86 in mice. Transplant Proc 1996;28:1039.
14. Walunas TL, Lenschow DJ, Bakker CY, et al. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1994;1:405.
15. Perros P, Weightman DR. Measurement of cell proliferation by enzyme-linked immunosorbent assay (ELISA) using a monoclonal antibody to bromodeoxyuridine. Cell Prolif 1991;24:517.
16. Sander B, Hoiden I, Andersson U, et al. Similar frequencies and kinetics of cytokine producing cells in murine peripheral blood and spleen. Cytokine detection by immunoassay and intracellular immunostaining. J Immunol Methods 1993;166:201.
17. Abrams JS, Roncarolo MG, Yssel H, et al. Strategies of anti-cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples. Immunol Rev 1992;127:5.
18. Bushell A, Niimi M, Morris PJ, et al. Evidence for immune regulation in the induction of transplantation tolerance: A conditional but limited role for IL-4. J Immunol 1999;162:1359.
19. Ito H, Hamano K, Gohra H, et al. Role of microchimerism on long-term graft survival after donor-specific transfusion in a rat heart transplantation model. Transplant Proc 1998;30:3862.
20. Matsuura Y, Matsuoka T, Fuse Y. Ultrastructural and immunohistochemical studies on the ontogenic development of bronchus-associated lymphoid tissue (BALT) in the rat: special reference to follicular dendritic cells. Eur Respir J 1992;5:824.
21. Tango M, Suzuki E, Gejyo F, et al. The presence of specialized epithelial cells on the bronchus-associated lymphoid tissue (BALT) in the mouse. Arch Histol Cytol 2000;63:81.
22. Faria AM, Weiner HL. Oral tolerance: Mechanisms and therapeutic applications. Adv Immunol 1999;73:153.
23. + regulatory cells generated by intratracheal delivery of alloantigen. Transplant Proc (in press).
24. Zheng XX, Markees TG, Hancock WW, et al. CTLA4 signals are required to optimally induce allograft tolerance with combined donor-specific transfusion and anti-CD154 monoclonal antibody treatment. J Immunol 1999;162:4983.
25. Bolling S, Lin H, Wei R, Turka L. Preventing allograft rejection with CTLA4Ig: effect of donor-specific transfusion route or timing. J Heart Lung Transplant 1996;15:928.
26. Judge TA, Wu Z, Zheng XG, et al. The role of CD80, CD86, and CTLA4 in alloimmune responses and the induction of long-term survival. J Immunol 1999;162:1947.
27. Samoilova EB, Horton JL, Zhang H, et al. CTLA-4 is required for the induction of high dose oral tolerance. Int Immunol 1998;10:491.
28. Salomon B, Lenschow DJ, Rhee L, et al. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 2000;12:431.
29. + regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med 2000;192:303.
30. Cottrez F, Hurst SD, Coffman R, et al. T regulatory cells 1 inhibit a Th2-specific response in vivo. J Immunol 2000;165(9):4848.
31. Hara M, Kingsley CI, Niimi M, et al. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol 2001; 166:3789.